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Clinics and pathology 
Disease  
Biphasic Synovial Sarcoma 
Pathology 
The excised tumor consisted of a single 3-cm nodulus 
with relatively well-defined borders and a grey cut 
surface. No necrosis was seen. In histological sections 
stained with H and E, the tumor was mainly composed 
of uniform, closely packed spindle cells, with a high 
nuclear/cytoplasmic ratio and finely dispersed 
chromatin. The tumor cells were arranged in fascicles 
and whorls, with small foci of calcification. The mitotic 
activity was low. In addition, small and irregular 
glandular formations lined by flattened cuboidal cells 
were noted in the peripheral parts of the tumor, 
supporting the diagnosis of biphasic synovial sarcoma. 
These cells, as well as many spindle cells, expressed 
cytokeratins and epithelial membrane antigen (EMA). 
Treatment 
The patient was given postoperative chemo- and 
radiotherapy. 
Evolution 
Four months postoperatively, the patient is alive 
without any sign of local recurrence or metastatic 
disease. 
Cytogenetics 
Cytogenetics morphological 
48,XY,+mar1,+mar2[5]/47,idem, 
dic(19;22)(q13;q13)[3]. 
Cytogenetics molecular 
With a pool of SSX BAC probes, one and two signals 
were seen on mar1 and mar2, respectively. On the latter 
marker chromosome, one of the signals co-localized 
with the signal from RP5-1005F21, suggesting the 
presence of a fusion gene between SS18L1 and one of 
the SSX genes. 
Probes 
RP5-1005F21 (SS18L1), RP11-552E4 and RP11-
344N17 (pool of SSX genes). 
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Top: Partial karyotype showing G-banded chromosomes X, 18, 20 and markers 1 and 2. 
Bottom: FISH cohybridization using a pool of RP11-552E4 and RP11-344N17 (red), RP5-1005F21 (purple), and pZ20 (green) as probes 
for chromosomes X, 20, and the two markers. The results on mar2 are shown as a three-color image (left), as well as separately for 
each of the probes (right). 
 
Genes involved and Proteins 
SS18L1 
Location: 20q13.33 
Note: Paralogous gene to SS18 (18q11.2). 
DNA/RNA 
Genomic (chr20:60,169,869-60,189,352). Transcript of 
4566 bp (NM_198935). 
SSX1 
Location: Xp11.23 
Note: Gene belonging to the SSX gene family. 
DNA/RNA 
Genomic (chrX:47,999,741-48,011,823). Transcript of 
1271 bp (NM_005635). 
Protein 
188 amino acids (Q16384). 
Result of the chromosomal 
anomaly 
Hybride Gene 
Description 
Nucleotide 1216 (exon 10) of SS18L1 (Accession  
Number XM_037202) was fused in-frame with nt 422 
(exon 6) of SSX1 (Accession Number X86174). 
Fusion protein 
Description 
In the putative SS18L1/SSX1 chimeric protein, the last 
8 amino acid residues of the SS18L1 protein are 
replaced by 78 amino acids from the COOH-terminal 
part of SSX1. By analogy with what is presumed to be 
the case for the SS18/SSX fusion protein, 
SS18L1/SSX1 is likely to show an altered 
transcriptional pattern, with the COOH-terminal SSX 
domain redirecting the SS18L1 activation domain to 
new target promoters. 
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